Journal articleN Engl J Med2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
- Journal
- N Engl J Med
- Published
- 1 December 2018
- Citations
- 2,219
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Trials 11
- Builds on itTrial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma NCT01526135↗
- BackgroundctDNA Monitoring After Pancreatic Cancer Surgery (K-4CARE Lite Study) NCT07597252↗
- BackgroundUsing Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment NCT06574620↗
- BackgroundNeoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer NCT07081360↗
- BackgroundPancreatic Cancer Detection Consortium NCT06388967↗
- BackgroundNeoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer NCT05132504↗
- BackgroundLiquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC) NCT05346536↗
- BackgroundConcurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer NCT05262452↗
- BackgroundSequential Treatment With GEMBRAX and Then FOLFIRINOX Followed by Stereotactic MRI-guided Radiotherapy in Patients With… NCT04570943↗
- BackgroundPancreatic Surgery in Elderly Patients NCT04893408↗
- BackgroundPancreatic and Periampullary Tumors in Greenland Inuit NCT05595811↗